RBC Capital Reiterates Sector Perform on Darden Restaurants (DRI) Following 1Q Report
- Wall Street closes higher as investors digest earnings, megacap outlook
- Tesla touts acceleration of new models, but Q1 results fall short of estimates
- JPMorgan is worried about further S&P 500 sell-off potential
- Oil rises as dollar slips, focus shifts to economic data
- China acquired top-end Nvidia AI chips despite recent US ban- Reuters
- Fisker (FSR) Appoints Michael Healy as Chief Restructuring Officer
- Kroger (KR), Albertsons and C&S Wholesale Grocers Announce an Updated and Expanded Divestiture Plan
- Costar Group (CSGP) to Acquire Matterport (MTTR) for $5.50/sh Cash and Stock
- Jaguar Health (JAGX) Files $75M Mixed Shelf
- Seagate Technology (STX) Enters $600M Asset Purchase Agreement with Avago
- After-hours movers: Tesla, Texas Instruments, Seagate, Visa and more
- Midday movers: PepsiCo, JetBlue fall; GM, Danaher and UPS rise
- After-hours movers: Cadence Design Systems, Cleveland-Cliffs, Riot Platforms, and more
- Midday movers: Tesla, Li Auto and CNH Industrial fall; Salesforce rises
- Midday movers: Netflix, Super Micro fall; Paramount Global gains
Oppenheimer Reiterates Outperform on Darden Restaurants (DRI) Following 1Q Report
October 5, 2016 9:51 AM EDTOppenheimer reiterated an Outperform rating and $70.00 price target on Darden Restaurants (NYSE: DRI) following the company's 1Q earnings report. DRI reported EPS of $0.88, ahead of the Street's $0.82 estimate. Management raised F17E EPS guidance to $3.87-$3.97 (was $3.80-$3.90), vs. Street's $3.87.
Analyst Brian Bittner... More
Options with increasing volume: MTDR BRCD VNO
October 4, 2016 9:47 AM EDTOptions with increasing volume: MTDR BRCD VNO DRI BRCD NEM DAL NFLX HPE SDRL ETSY AAL NBR DOV BLDP TGP MUX
... MorePre-Open Stock Movers 10/04: (SMMT) (SDRL) (ARLZ) Higher; (TRIB) (IRMD) (TWTR) Lower (more...)
October 4, 2016 9:22 AM EDTToday's Pre-Open Stock Movers
Summit Therapeutics plc (Nasdaq: SMMT) 80% HIGHER; Sarepta Therapeutics (Nasdaq: SRPT) and Summit Therapeutics plc (Nasdaq: SMMT) announced that they have entered into an exclusive license and collaboration agreement granting Sarepta rights in Europe, as well as in Turkey and the Commonwealth of Independent States (the licensed territory), to Summits utrophin modulator pipeline, including its lead clinical candidate, ezutromid, for the treatment of Duchenne muscular dystrophy (DMD). As part of the agreement, Sarepta also obtains an option... More
Darden Restaurants (DRI) Tops Q1 EPS by 6c; Boosts FY17 EPS Outlook; $500M Stock Buyback Approved
October 4, 2016 7:06 AM EDTDarden Restaurants (NYSE: DRI) reported Q1 EPS of $0.88, $0.06 better than the analyst estimate of $0.82. Revenue for the quarter came in at $1.71 billion versus the consensus estimate of $1.72 billion.
Same-restaurant sales increased 1.3% for the quarter.
Stock Buyback News:
During the... More